[Abstract #95] Role of Oncology Advanced Practitioners to Enhance Clinical Research

Presented at the 2020 ASCO Quality Care Symposium, October 9 to October 10, 2020.

Authors

Christa M. Braun-Inglis, NP1, Leigh M. Boehmer, PharmD2, Laura J. Zitella, NP3, Brianna W. Hoffner, NP4, Yurii B. Shvetsov, PhD1, Jessica M. Rhee, MD1, Randall A. Oyer, MD5, Al B. Benson, III, MD6

1University of Hawaii Cancer Center, Honolulu, HI; 2Association of Cancer Care Centers, Rockville, MD; 3University of California, San Francisco, CA; 4Harborside, Huntington, NY; 5Ann B. Barshinger Cancer Institute, Penn Medicine Lancaster General Health, Lancaster, PA; 6Northwestern Medicine, Chicago, IL

Background

Oncology Advanced Practitioners (APs), including nurse practitioners, clinical nurse specialists, physician assistants and pharmacists, are highly trained, skilled health care providers that contribute significantly to quality cancer care.

Given low clinical trial enrollment among adult oncology patients, understanding current research responsibilities of APs could lead to identification of opportunities to leverage this workforce to enhance accrual and conduct of clinical trials.

Access more clinical research and trials content in the 2020-21 ACCC President’s Theme, Community Oncology Can Close the Gap in Cancer Research.